Pharma Rep Focus

Search:

DAY

WEEK

MONTH

YEAR

Select your country:
Sign up | Log in

tag ms-society

Cost of disease-modifying therapies for multiple sclerosis continues to rise in US

Pharmaceutical Technology

MAY 19, 2023

Multiple sclerosis (MS) is a primary autoimmune disease in which inflammation is a core contributor to the degeneration of the central nervous system (CNS), leading to neurological disability and affecting sensory, visual, motor, and autonomic systems. DMTs for MS have a high price tag, particularly in the US.

Prospecting

Prospecting Marketing Patients Leads

Developing point-of-care CAR T manufacturing

European Pharmaceutical Review

DECEMBER 27, 2023

This data has been captured by CAR T-cell registries that were established first by the Center for International Blood and Marrow Transplant Research (CIBMTR) and later by the European Society for Blood and Marrow Transplantation (EBMT). This is in addition to its considerable price tag. Available from: [link] Sun Z, Liu MS.

Manufacturing

Manufacturing Food and Drug Administration Patients Pharma

Cost of disease-modifying therapies for multiple sclerosis continues to rise in US

Developing point-of-care CAR T manufacturing

Stay Connected